title: [Coxibs].
authors.affiliation: Rheumatologie, Klaus-Miehlke Klinik, Leibnizstr. 23, 65191, Wiesbaden, Deutschland. wbolten@em.uni-frankfurt.de.
authors.forename: W W
authors.initials: WW
authors.lastname: Bolten
authors.affiliation: Praxiszentrum St. Bonifatius, St.-Bonifatius-Str. 5, 81541, München, Deutschland.
authors.forename: K
authors.initials: K
authors.lastname: Krüger
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D019317:Evidence-Based Medicine; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D012216:Rheumatic Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D016861:Cyclooxygenase Inhibitors